Boston Scientific Announces First Implant and Market Launch of PROMUS Element ... Sacramento Bee 1, 2012 -- /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces first patient use and European market launch of the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System. The first patient implant in Europe ... Drug-eluting stent: Boston Scientific launches new Promus Element Plus in EU Boston Scientific Unveils European Market Launch Of PROMUS Element Plus |
